Skip to content
OpenCapital
Get started

NeoVolta NEOV Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation Bio logo
Nuvation BioNUVB
5.8M0.0%
KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M—
Unusual Machines logo
Unusual MachinesUMAC
0-100%
The Marygold Companies logo
The Marygold CompaniesMGLD
82.5K—
Safe Pro Group Inc. logo
Safe Pro Group Inc.SPAI
51.2K—
KRAKacquisition logo
KRAKacquisition KRAQ
0—

Other financials

Income statement

See full
Revenue$2.0M+0.5%
Gross profit$927.8K+80.3%
Operating income-$2.6M-91.5%
Net income-$3.0M-109%
EPS (diluted)-$0.08-100%

Balance sheet

See full
Cash & equivalents$11.5M+2,042%
Total debt$1.5M+2.2%
Total equity$22.2M+480%
Total assets$25.7M+349%

Cash flow

See full
Operating cash flow-$3.6M-74.6%

Valuation

See full
Market cap$172.96M+43.6%
Enterprise value$162.93M+33.1%
P/S9.6×-4.7×

Profitability

See full
Gross margin21.3%-1.0pp
Operating margin-52%-16.1pp
Net margin-63.4%-16.2pp

Returns & leverage

See full
Return on equity-88.1%-3.4pp
Debt / equity0.1×-0.3×
Current ratio8.1×+4.3×

Where this comes from

Reported directly by NeoVolta in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.

The official record: NeoVolta’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoVolta's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoVolta's warrants and rights outstanding?
NeoVolta (NEOV) reported warrants and rights outstanding of 1.1M in Q1 2026.
How has NeoVolta's warrants and rights outstanding changed year-over-year?
NeoVolta's warrants and rights outstanding decreased by 8.4% year-over-year, from 1.2M to 1.1M.
What does warrants and rights outstanding mean?
This represents the total number or value of derivative instruments that grant holders the right to purchase company equity at a specified price. These instruments represent potential future dilution for existing shareholders upon exercise. Investors monitor this to understand the impact of potential equity issuance on earnings per share and ownership stakes.